Form 4 for UNH UnitedHealth Group
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-16 · accession 0000731766-24-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-20 | 2024-02-16 | UNH | THOMPSON BRIAN R | CEO, UnitedHealthcare | F - Tax | $521.18 | -59.5K | 49.1K | -55% | -$31.00M |
| DM | 2024-02-20 | 2024-02-16 | UNH | THOMPSON BRIAN R | CEO, UnitedHealthcare | M - OptEx | $255.22 | +82.3K | 38.2K | New | +$21.02M |
| D | 2024-02-20 | 2024-02-16 | UNH | THOMPSON BRIAN R | CEO, UnitedHealthcare | S - Sale+OE | $521.00 | -28.9K | 25.5K | -53% | -$15.08M |
| DM | 2024-02-20 | 2024-02-16 | UNH | THOMPSON BRIAN R | CEO, UnitedHealthcare | M - OptEx | $0.00 | -82.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-16 | F | D | 12,246 | $521.13 | 39,523.69 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-16 | M | A | 21,377 | $262.98 | 60,900.69 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-16 | F | D | 18,320 | $521.18 | 54,485.69 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-16 | M | A | 13,008 | $243.20 | 58,292.69 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-16 | F | D | 15,616 | $521.24 | 45,284.69 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-16 | F | D | 4,074 | $521.07 | 34,088.69 | D | — | — | |
| 7 | Common | Common Stock | 2024-02-16 | M | A | 23,747 | $302.20 | 72,805.69 | D | — | — | |
| 8 | Common | Common Stock | 2024-02-16 | F | D | 9,234 | $521.18 | 49,058.69 | D | — | — | |
| 9 | Common | Common Stock | 2024-02-16 | S | D | 28,943 | $521.00 | 25,542.69 | D | — | — | (F1) This transaction was executed in multiple trades ranging from $520.320 to $522.420 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 10 | Common | Common Stock | 2024-02-16 | M | A | 17,681 | $226.64 | 51,769.69 | D | — | — | |
| 11 | Common | Common Stock | 2024-02-16 | M | A | 6,535 | $160.31 | 38,162.69 | D | — | — | |
| 12 | Derivative | Non-Qualified Stock Options (right to buy) | 2024-02-16 | M | D | 13,008 | $0.00 | 0 | D | $243.20 · — to 2029-08-12 | 13,008 Common Stock | (F5) The non-qualified stock options vested at a rate of 25% annually on August 12 from the years 2020 through 2023. |
| 13 | Derivative | Non-Qualified Stock Options (right to buy) | 2024-02-16 | M | D | 23,747 | $0.00 | 0 | D | $302.20 · — to 2030-02-13 | 23,747 Common Stock | (F6) The non-qualified stock options vested at a rate of 25% annually on February 13 from the years 2021 through 2024. |
| 14 | Derivative | Non-Qualified Stock Options (right to buy) | 2024-02-16 | M | D | 6,535 | $0.00 | 0 | D | $160.31 · — to 2027-02-08 | 6,535 Common Stock | (F2) The non-qualified stock options vested at a rate of 25% annually on February 8 from the years 2018 through 2021. |
| 15 | Derivative | Non-Qualified Stock Options (right to buy) | 2024-02-16 | M | D | 17,681 | $0.00 | 0 | D | $226.64 · — to 2028-02-13 | 17,681 Common Stock | (F3) The non-qualified stock options vested at a rate of 25% annually on February 13 from the years 2019 through 2022. |
| 16 | Derivative | Non-Qualified Stock Options (right to buy) | 2024-02-16 | M | D | 21,377 | $0.00 | 0 | D | $262.98 · — to 2029-02-26 | 21,377 Common Stock | (F4) The non-qualified stock options vested at a rate of 25% annually on February 26 from the years 2020 through 2023. |